SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-24-000081
Filing Date
2024-09-10
Accepted
2024-09-10 16:26:10
Documents
14
Period of Report
2024-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240910.htm   iXBRL 8-K 33715
  Complete submission text file 0000200406-24-000081.txt   228933

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240910.xsd EX-101.SCH 3800
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240910_def.xml EX-101.DEF 8616
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240910_lab.xml EX-101.LAB 33327
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240910_pre.xml EX-101.PRE 20041
16 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240910_htm.xml XML 7715
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 241290376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)